Pathogenic variants in CHD proteins contribute to the development of a range of neurological disorders, such as CHD1 in Pilarowski-Bjornsson syndrome [218], CHD3 in Snijders Blok-Campeau syndrome (SNIBCPS) [116], CHD4 in Sifram-Hitz-Weiss syndrome [219], CHD7 [220] and CHD8 [119] in Autism Spectrum Disorder (ASD). This evidence concerns the gene CHD1 and Snijders Blok-Campeau syndrome.